BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Alpheus Presents Data on Serial LDH Kinetics as a Potential Blood-Based Biomarker in Glioblastoma

  October 27, 2026

   · 

  3 min read
• Press Releases

  Alterome Therapeutics to Present First Clinical Data from Phase 1/1b Trial of ALTA3263 in KRAS-Mutant Advanced Solid Tumors in Late-Breaking Presentation at the 38th EORTC-NCI-AACR Symposium

  October 27, 2026

   · 

  2 min read
• Press Releases

  Laxxon Medical Appoints Matthew Cascio as Vice President and Head of Business Development

  October 27, 2026

   · 

  3 min read
• Press Releases

  AcuraStem Receives Hoffman ALS Clinical Trial Award to Support Phase 1 Trial of AS-241, the Clinical Candidate of its UNC13A Program

  October 27, 2026

   · 

  4 min read
• Press Releases

  Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile

  October 27, 2026

   · 

  4 min read
• Press Releases

  Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification

  October 27, 2026

   · 

  3 min read
• Press Releases

  Adults Living with Familial Chylomicronaemia Syndrome (FCS) in England and Wales Have REDEMPLO® (Plozasiran) as a New Treatment Option to Reduce Triglycerides

  October 27, 2026

   · 

  7 min read
• Press Releases

  Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress

  October 27, 2026

   · 

  6 min read
• Press Releases

  KROMATID Selected as Industry Resource Partnership Program Member by the California Institute for Regenerative Medicine (CIRM)

  October 27, 2026

   · 

  2 min read
• Press Releases

  Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026

  October 27, 2026

   · 

  9 min read